Anti-O-Linked N-Acetylglucosamine antibody [EPR19847]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
- IP
Unknown
Immunoprecipitation - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (AB202665)
O-Linked N-Acetylglucosamine was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate with ab202665 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab202665 at 1/1,000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab202665 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab202665 in HeLa whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (ab202665)
false
- WB
Lab
Western blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (AB202665)
Blocking buffer and concentration 5% NFDM/TBST
Diluting buffer and concentration 5% NFDM/TBST
Ac45SGlcNAc, an inhibitor of OGT, decreases O-GlcNAc modification. Thiamet-G, an inhibitor of OGA, increases O-GlcNAc modification.
These two chemicals were kindly provided by our collaborator Dr. Xing Chen, Peking University.
The expression pattern is consistent with reference (PMID : 27716624)
All lanes:
Western blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (ab202665) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) treated with DMSO (0.4%) as baseline control. whole cell lysate at 20 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell) treated with 200 μM Ac45SGlcNAc for 24 hours whole cell lysate at 20 µg
Lane 4:
HeLa (human cervix adenocarcinoma epithelial cell) treated with 200 μM Thiamet-G for 24 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 50-100 kDa
false
Exposure time: 3s
- WB
Unknown
Western blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (AB202665)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1 : 4 seconds; Lane 2 : 15 seconds.
All lanes:
Western blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (ab202665) at 1/1000 dilution
Lane 1:
HEK-293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
- WB
Lab
Western blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (AB202665)
Blocking buffer and concentration : 5% NFDM/TBST
Diluting buffer and concentration : 5% NFDM/TBST
Exposure time :
Lane 1 : 8 seconds;
Lane 2 : 3 seconds;
Lane 3 : 26 seconds.
All lanes:
Western blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (ab202665) at 1/1000 dilution
Lane 1:
Rat brain lysate at 10 µg
Lane 2:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Lane 3:
SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 20-100 kDa
false
- Dot
Unknown
Dot Blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (AB202665)
Dot Blot - Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] (ab202665 1 : 1000 dilution).
Lane 1 : O-linked N-acetylglucosamine (O-GlcNAc) peptide 10 ng.
Lane 2 : Non-O-GlcNAc peptide 10 ng.
Blocking/Dilution buffer : 5% NFDM/TBST.
Secondary : Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051 1 : 100,000 dilution).
Exposure time of 3 minutes.
The peptides were kindly provided by our collaborator Dr. Xing Chen, Peking University.
Related conjugates and formulations (1)
-
Anti-O-Linked N-Acetylglucosamine antibody [EPR19847] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
O-GlcNAc modifies proteins influencing cellular processes such as transcription signal transduction and stress response. It is involved in the regulation of transcription factors like Sp1 and NF-kB and is associated with the O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) enzymes which respectively add and remove the GlcNAc group. O-GlcNAc functions in a manner similar to phosphorylation often competing with it on the same or adjacent serine/threonine sites. This modification is not part of a permanent protein complex but dynamically modulates protein interactions and activity.
Pathways
This modification plays a fundamental role in pathways related to nutrient sensing and insulin signaling. It modulates proteins such as insulin receptor substrate 1 (IRS1) and Akt to link nutrient status to cellular responses. The hexosamine biosynthetic pathway (HBP) is an important pathway in which O-GlcNAc is synthesized. Through these pathways it impacts cellular signaling and metabolism influencing processes like cellular growth and apoptosis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Chemico-biological interactions 382:110629 PubMed37442287
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com